Yeo, Junila M.

HRN: 19 61 46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/21/2022
09/27/2022
IV
1.5gm
Q8
UTI Urosepsis
Waiting Final Action 
02/22/2023
CEFUROXIME 1.5GM (VIAL)
02/22/2023
02/28/2023
IVT
1.5g
Q8
Sepsis
Waiting Final Action 
02/22/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/22/2023
02/28/2023
IVT
500mg
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: